Literature DB >> 19130463

Racial disparities in the development of breast cancer metastases among older women: a multilevel study.

Mario Schootman1, Donna B Jeffe, William E Gillanders, Rebecca Aft.   

Abstract

BACKGROUND: Distant metastases are the most common and lethal type of breast cancer relapse. The authors examined whether older African American breast cancer survivors were more likely to develop metastases compared with older white women. They also examined the extent to which 6 pathways explained racial disparities in the development of metastases.
METHODS: The authors used 1992-1999 Surveillance, Epidemiology, and End Results (SEER) data with 1991-1999 Medicare data. They used Medicare's International Classification of Diseases, Ninth Revision, Clinical Modification codes to identify metastases of respiratory and digestive systems, brain, bone, or other unspecified sites. The 6 pathways consisted of patient characteristics, tumor characteristics, type of treatment received, access to medical care, surveillance mammography use, and area-level characteristics (poverty rate and percentage African American) and were obtained from the SEER or Medicare data.
RESULTS: Of the 35,937 women, 10.5% developed metastases. In univariate analysis, African American women were 1.61 times (95% confidence interval [CI], 1.54-1.83) more likely to develop metastasis than white women. In multivariate analysis, tumor grade, stage at diagnosis, and census-tract percentage African American explained why African American women were more likely to develop metastases than white women (hazard ratio, 0.84; 95% CI, 0.68-1.03).
CONCLUSIONS: Interventions to reduce late-stage breast cancer among African Americans also may reduce racial disparities in subsequent increased risk of developing metastasis. African Americans diagnosed with high-grade breast cancer could be targeted to reduce their risk of metastasis. Future studies should identify specific reasons why the racial distribution in census tracts was associated with racial disparities in the risk of breast cancer metastases. (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19130463      PMCID: PMC2756080          DOI: 10.1002/cncr.24087

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  Disaggregating the effects of race and poverty on breast cancer outcomes.

Authors:  Otis W Brawley
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

2.  Identifying breast cancer patients at high risk for bone metastases.

Authors:  M Colleoni; A O'Neill; A Goldhirsch; R D Gelber; M Bonetti; B Thürlimann; K N Price; M Castiglione-Gertsch; A S Coates; J Lindtner; J Collins; H J Senn; F Cavalli; J Forbes; A Gudgeon; E Simoncini; H Cortes-Funes; A Veronesi; M Fey; C M Rudenstam
Journal:  J Clin Oncol       Date:  2000-12-01       Impact factor: 44.544

Review 3.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

4.  Unequal treatment: confronting racial and ethnic disparities in health care.

Authors:  Alan Nelson
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

5.  Preventable hospitalizations in primary care shortage areas. An analysis of vulnerable Medicare beneficiaries.

Authors:  M L Parchman; S D Culler
Journal:  Arch Fam Med       Date:  1999 Nov-Dec

6.  Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996.

Authors:  X Du; J S Goodwin
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

7.  Race, socioeconomic status, and breast cancer treatment and survival.

Authors:  Cathy J Bradley; Charles W Given; Caralee Roberts
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

8.  Tumor characteristics in African American and white women.

Authors:  H Furberg; R Millikan; L Dressler; B Newman; J Geradts
Journal:  Breast Cancer Res Treat       Date:  2001-07       Impact factor: 4.872

9.  Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms.

Authors:  Whitney M Randolph; Jonathan D Mahnken; James S Goodwin; Jean L Freeman
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

10.  Utility of the SEER-Medicare data to identify chemotherapy use.

Authors:  Joan L Warren; Linda C Harlan; Angela Fahey; Beth A Virnig; Jean L Freeman; Carrie N Klabunde; Gregory S Cooper; Kevin B Knopf
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  16 in total

1.  Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women.

Authors:  Matthew P Banegas; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2012-07-08       Impact factor: 4.872

2.  Referrals among cancer services organizations serving underserved cancer patients in an urban area.

Authors:  Jenine K Harris; Julianne Cyr; Bobbi J Carothers; Nancy B Mueller; Victoria V Anwuri; Aimee I James
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

3.  Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data.

Authors:  Hajime Uno; Debra P Ritzwoller; Angel M Cronin; Nikki M Carroll; Mark C Hornbrook; Michael J Hassett
Journal:  JCO Clin Cancer Inform       Date:  2018-12

Review 4.  Population and target considerations for triple-negative breast cancer clinical trials.

Authors:  Terry Hyslop; Yvonne Michael; Tiffany Avery; Hallgeir Rui
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

5.  White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival among Adults Aged 85 Years and Older in the United States.

Authors:  Jessica L Krok-Schoen; James L Fisher; Ryan D Baltic; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

6.  Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.

Authors:  Michael J Hassett; Debra P Ritzwoller; Nathan Taback; Nikki Carroll; Angel M Cronin; Gladys V Ting; Deb Schrag; Joan L Warren; Mark C Hornbrook; Jane C Weeks
Journal:  Med Care       Date:  2014-10       Impact factor: 2.983

7.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

8.  Changing trends of breast cancer survival in sultanate of oman.

Authors:  Shiyam Kumar; Ikram A Burney; Adel Al-Ajmi; Mansour S Al-Moundhri
Journal:  J Oncol       Date:  2010-10-25       Impact factor: 4.375

9.  Do socially deprived urban areas have lesser supplies of cancer care services?

Authors:  Elizabeth B Lamont; Yulei He; S V Subramanian; Alan M Zaslavsky
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients.

Authors:  Stephanie B Wheeler; William R Carpenter; Jeffrey Peppercorn; Anna P Schenck; Morris Weinberger; Andrea K Biddle
Journal:  Breast Cancer Res Treat       Date:  2012-01-22       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.